120 related articles for article (PubMed ID: 25687162)
1. A head-to-head comparison of homocysteine and cystatin C as pre-procedure predictors for contrast-induced nephropathy in patients undergoing coronary computed tomography angiography.
Li S; Tang X; Peng L; Luo Y; Zhao Y; Chen L; Dong R; Zhu J; Chen Y; Liu J
Clin Chim Acta; 2015 Apr; 444():86-91. PubMed ID: 25687162
[TBL] [Abstract][Full Text] [Related]
2. Preprocedure and Postprocedure Predictive Values of Serum β2-Microglobulin for Contrast-Induced Nephropathy in Patients Undergoing Coronary Computed Tomography Angiography: A Comparison With Creatinine-Based Parameters and Cystatin C.
Li S; Zheng Z; Tang X; Peng L; Luo Y; Dong R; Zhao Y; Liu J
J Comput Assist Tomogr; 2015; 39(6):969-74. PubMed ID: 26248154
[TBL] [Abstract][Full Text] [Related]
3. Prediction of contrast-induced nephropathy in patients with serum creatinine levels in the upper normal range by cystatin C: a prospective study in 374 patients.
Wacker-Gußmann A; Bühren K; Schultheiss C; Braun SL; Page S; Saugel B; Schmid S; Mair S; Schoemig A; Schmid RM; Huber W
AJR Am J Roentgenol; 2014 Feb; 202(2):452-8. PubMed ID: 24450691
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of serum cystatin C for early recognition of contrast induced nephropathy in Western Indians undergoing cardiac catheterization.
Shukla AN; Juneja M; Patel H; Shah KH; Konat A; Thakkar BM; Madan T; Prajapati J
Indian Heart J; 2017; 69(3):311-315. PubMed ID: 28648419
[TBL] [Abstract][Full Text] [Related]
5. Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial.
Kim BJ; Sung KC; Kim BS; Kang JH; Lee KB; Kim H; Lee MH
Int J Cardiol; 2010 Feb; 138(3):239-45. PubMed ID: 18793808
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous coronary intervention causes increase of serum cystatin C concentration even in the patients with a low risk of contrast-induced nephropathy.
Tanaga K; Tarao K; Nakamura Y; Inoue T; Jo K; Ishikawa T; Miyazaki A
Cardiovasc Interv Ther; 2012 Sep; 27(3):168-73. PubMed ID: 22692693
[TBL] [Abstract][Full Text] [Related]
7. Impact of contrast-induced nephropathy and cardiovascular events by serum cystatin C in renal insufficiency patients undergoing cardiac catheterization.
Ishibashi Y; Yamauchi M; Musha H; Mikami T; Kawasaki K; Miyake F
Angiology; 2010 Nov; 61(8):724-30. PubMed ID: 20947866
[TBL] [Abstract][Full Text] [Related]
8. Relation of homocysteinemia to contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.
Kim SJ; Choi D; Ko YG; Kim JS; Han SH; Kim BK; Kang SW; Hong MK; Jang Y; Choi KH; Yoo TH
Am J Cardiol; 2011 Oct; 108(8):1086-91. PubMed ID: 21791335
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum cystatin C level is an independent predictor of contrast-induced nephropathy and adverse outcomes in patients with peripheral artery disease undergoing endovascular therapy.
Kim GS; Ko YG; Shin DH; Kim JS; Kim BK; Choi D; Hong MK; Jang Y
J Vasc Surg; 2015 May; 61(5):1223-30. PubMed ID: 25595408
[TBL] [Abstract][Full Text] [Related]
10. Contrast Volume to Cystatin C-Based Glomerular Filtration Ratio Predicts the Risk of Contrast-Induced Nephropathy After Cardiac Catheterization.
Zhao JB; Liu Y; Wu DX; Chen JY; Duan CY; Chen SQ; Tan N
Angiology; 2017 Mar; 68(3):207-215. PubMed ID: 27166381
[TBL] [Abstract][Full Text] [Related]
11. Valuable markers for contrast-induced nephropathy in patients undergoing cardiac catheterization.
Kato K; Sato N; Yamamoto T; Iwasaki YK; Tanaka K; Mizuno K
Circ J; 2008 Sep; 72(9):1499-505. PubMed ID: 18724030
[TBL] [Abstract][Full Text] [Related]
12. Significance of Cystatin C for Early Diagnosis of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography.
Wang M; Zhang L; Yue R; You G; Zeng R
Med Sci Monit; 2016 Aug; 22():2956-61. PubMed ID: 27548357
[TBL] [Abstract][Full Text] [Related]
13. Cystatin C as biomarker of contrast-induced nephropathy in pediatric cardiac angiography.
Osman Ö; Ayee Deniz O; Abdülkadir E; Cihat Ş; Hüsnü Oğuz S; Avse Banu Ç
Turk J Med Sci; 2014; 44(2):178-85. PubMed ID: 25536721
[TBL] [Abstract][Full Text] [Related]
14. Relationship between pre-procedural microalbuminuria and renal functional changes after coronary computed tomography in diabetic patients.
Isobe S; Yamada T; Yuba M; Hayashi M; Ishii H; Murohara T
J Cardiol; 2017 Apr; 69(4):666-670. PubMed ID: 27424108
[TBL] [Abstract][Full Text] [Related]
15. Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions.
Ribichini F; Gambaro G; Graziani MS; Pighi M; Pesarini G; Pasoli P; Anselmi M; Ferrero V; Yabarek T; Sorio A; Rizzotti P; Lupo A; Vassanelli C
Clin Chem; 2012 Feb; 58(2):458-64. PubMed ID: 22166252
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.
Ivanes F; Isorni MA; Halimi JM; Fauchier L; Saint Etienne C; Babuty D; Angoulvant D; Brunet-Bernard A
Arch Cardiovasc Dis; 2014; 107(8-9):424-32. PubMed ID: 25082735
[TBL] [Abstract][Full Text] [Related]
17. Contrast nephropathy in high-risk patients undergoing coronary angiography and intervention.
Uddin MA; Rabbani MA; Jafary FH; Bhatti MA; Islam M
J Coll Physicians Surg Pak; 2005 Dec; 15(12):791-4. PubMed ID: 16398973
[TBL] [Abstract][Full Text] [Related]
18. Cystatin C and creatinine as markers for radiocontrast-induced nephropathy in patients treated with N-acetylcysteine.
Merkle M; Sauter M; Argirov M; Wörnle M
Ren Fail; 2010 Jan; 32(1):85-90. PubMed ID: 20113272
[TBL] [Abstract][Full Text] [Related]
19. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
Worasuwannarak S; Pornratanarangsi S
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554
[TBL] [Abstract][Full Text] [Related]
20. Relation of uric acid and contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention in the ED.
Saritemur M; Turkeli M; Kalkan K; Tanboga İH; Aksakal E
Am J Emerg Med; 2014 Feb; 32(2):119-23. PubMed ID: 24238488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
